Y Intercept Hong Kong Ltd Makes New $325,000 Investment in Healthcare Realty Trust Incorporated (NYSE:HR)

Y Intercept Hong Kong Ltd purchased a new stake in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 19,217 shares of the real estate investment trust's stock, valued at approximately $325,000.

A number of other institutional investors have also recently made changes to their positions in the stock. Harbor Capital Advisors Inc. boosted its position in shares of Healthcare Realty Trust by 16.4% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,945 shares of the real estate investment trust's stock valued at $84,000 after purchasing an additional 695 shares in the last quarter. O Shaughnessy Asset Management LLC raised its stake in Healthcare Realty Trust by 6.5% during the 4th quarter. O Shaughnessy Asset Management LLC now owns 11,530 shares of the real estate investment trust's stock worth $195,000 after buying an additional 706 shares during the period. Peak Financial Advisors LLC raised its stake in Healthcare Realty Trust by 6.8% during the 1st quarter. Peak Financial Advisors LLC now owns 11,413 shares of the real estate investment trust's stock worth $193,000 after buying an additional 728 shares during the period. ProShare Advisors LLC raised its stake in Healthcare Realty Trust by 4.8% during the 4th quarter. ProShare Advisors LLC now owns 16,581 shares of the real estate investment trust's stock worth $281,000 after buying an additional 756 shares during the period. Finally, Focus Financial Network Inc. raised its stake in Healthcare Realty Trust by 6.9% during the 1st quarter. Focus Financial Network Inc. now owns 11,868 shares of the real estate investment trust's stock worth $201,000 after buying an additional 762 shares during the period.

Healthcare Realty Trust Stock Performance

Shares of Healthcare Realty Trust stock traded up $1.14 on Friday, hitting $16.50. The company had a trading volume of 7,928,085 shares, compared to its average volume of 3,098,048. The stock has a market capitalization of $5.80 billion, a price-to-earnings ratio of -15.14 and a beta of 0.89. Healthcare Realty Trust Incorporated has a 1 year low of $14.09 and a 1 year high of $18.90. The stock has a 50 day moving average of $15.38 and a 200-day moving average of $15.88.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $287.07 million during the quarter, compared to the consensus estimate of $290.83 million. Healthcare Realty Trust had a negative return on equity of 7.06% and a negative net margin of 31.32%. During the same period last year, the business posted $0.38 earnings per share. Equities analysts anticipate that Healthcare Realty Trust Incorporated will post 1.59 earnings per share for the current year.

Healthcare Realty Trust Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th will be given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a yield of 5.8%. Healthcare Realty Trust's dividend payout ratio is currently -113.76%.

Insider Transactions at Healthcare Realty Trust

In other news, Director Thomas N. Bohjalian bought 2,500 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was acquired at an average cost of $14.71 per share, with a total value of $36,775.00. Following the completion of the transaction, the director directly owned 56,502 shares of the company's stock, valued at $831,144.42. This represents a 4.63% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.37% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on HR shares. Wedbush dropped their price target on Healthcare Realty Trust from $18.00 to $16.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Wall Street Zen downgraded Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research note on Saturday, May 31st. Wells Fargo & Company dropped their price target on Healthcare Realty Trust from $16.00 to $15.00 and set an "underweight" rating on the stock in a research note on Monday, June 2nd. Finally, JPMorgan Chase & Co. dropped their price target on Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating on the stock in a research note on Thursday, June 26th. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the company's stock. According to data from MarketBeat.com, Healthcare Realty Trust currently has a consensus rating of "Hold" and an average price target of $16.40.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.